Evidence map›Paper›PMID 41445547›Full record

ArticleInternational journal of developmental disabilities2025

Phase 1 clinical trial of ¡

Antonio F Pagán, Ana Esparza, Ana Ramirez, Miriam Ortiz, Linda Hernandez, Mary Beth Morgan, Geohanna Noel, Alejandro L Pagán, Jada Salas, Katherine Maurano and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of developmental disabilities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Antonio F PagánLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-4724-768X
Ana EsparzaLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Ana RamirezDepartment of Psychological Sciences, University of Texas Rio Grande Valley, Edinburg, TX, USA.
Miriam OrtizDepartment of Psychological Sciences, University of Texas Rio Grande Valley, Edinburg, TX, USA.
Linda HernandezDepartment of Clinical, Health, and Applied Sciences, University of Houston-Clear Lake, Houston, TX, USA.
Mary Beth MorganDepartment of Clinical, Health, and Applied Sciences, University of Houston-Clear Lake, Houston, TX, USA.
Geohanna NoelDepartment of Psychological Sciences, University of Texas Rio Grande Valley, Edinburg, TX, USA.
Alejandro L PagánLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Jada SalasLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Katherine MauranoLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Grace SattemLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Leela SydowLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Noor AhmedLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Katherine A LovelandLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.
Cecilia Montiel-NavaDepartment of Psychological Sciences, University of Texas Rio Grande Valley, Edinburg, TX, USA.
Ron AciernoLouis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, UTHealth Science Center at Houston, Houston, TX, USA.

Funding

NRSA Training CoreTL1TR003169 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHANDRA, JOYA, FROST, JEFFREY A. · 2019 to 2023
$3.7M
CTSA Postdoctoral T32 at the University of Texas Health Science Center at HoustonT32TR004904 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Joya Chandra, Jeffrey A. Frost · 2024 to 2026
$787k
Psychosocial and Neural Mechanisms for a Culturally and Linguistically Adapted Treatment for Bilingual Latino Young Adults with AutismK99HD118079 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Antonio Francisco Pagán · 2025 to 2026
$264k
NCATS NIH HHS T32 TR004904NCATS NIH HHS TL1 TR003169NICHD NIH HHS K99 HD118079
6 · The paper itself

Abstract

This Phase 1 clinical trial evaluated ¡Iniciando! la Adultez, a culturally adapted intervention for Latino autistic young adults (

Indexed as

autism spectrum disorderculturally tailored interventionLatino young adultsPhase 1 clinical trialtransition to adulthood

Identifiers

PMID41445547
PMCPMC12724526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.